Global healthcare company GlaxoSmithKline plans to close its facility on Allen Road in Carlisle by 2021, and move the plant’s operations to Puerto Rico.
“After careful review, GSK has decided to close the Carlisle, Pennsylvania site to consolidate volumes and generate efficiencies by moving the site’s production to our Guayama, Puerto Rico facility,” a statement from the company reads. “Based on this decision, which impacts approximately 260 employees, production will be phased out of Carlisle by mid-2021, with a full exit by the end of 2021. This transfer is not expected to impact the availability of the GSK products in the U.S. or at international levels. Whenever we identify the need for changes that impact the future of any of our sites and employees, we take great care to communicate these changes thoughtfully and provide support to employees.”